Screener
United Therapeutics UTHR Stockholders Equity
Stockholders Equity at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's stockholders equity?
- United Therapeutics (UTHR) reported stockholders equity of $6.4B in Q2 2026.
- How has United Therapeutics's stockholders equity changed year-over-year?
- United Therapeutics's stockholders equity decreased by 10.8% year-over-year, from $7.17B to $6.4B.
- What is the long-term trend for United Therapeutics's stockholders equity?
- Over 5 years (2020 to 2025), United Therapeutics's stockholders equity has grown at a 15.9% compound annual growth rate (CAGR), from $3.4B to $7.1B.
- What does stockholders equity mean?
- Stockholders Equity as reported by United Therapeutics Corp.
Ask your AI about United Therapeutics's stockholders equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude